Compare Estee Lauder Companies Inc (EL) vs McKesson Corporation (MCK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Estee Lauder Companies Inc vs McKesson Corporation — how do they compare? Estee Lauder Companies Inc trades at $88.05 (market cap $31.76B), while McKesson Corporation trades at $898 (market cap $105.14B). The key difference: McKesson Corporation is far larger — about 3.3× Estee Lauder Companies Inc's market cap, and Estee Lauder Companies Inc pays the higher dividend (1.59%). Which is the better fit depends on your goals.
| EL | MCK | |
|---|---|---|
Market Cap | $31.76B | $105.14B |
Sector | Consumer Staples | Health |
52-Week High | $119.61 | $995.69 |
52-Week Low | $67.23 | $659.01 |
Enterprise Value | $37.93B | $111.67B |
Dividend Yield | 1.59% | 0.42% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Estee Lauder Companies Inc
Estee Lauder is the world leader in the global prestige beauty market, participating across skincare (56% of fiscal 2022 sales), makeup (26%), fragrance (14%), and haircare (4%) categories, with popular brands such as Estee Lauder, Clinique, MAC, La Mer, Jo Malone, Aveda, Bobbi Brown, Too Faced, Origins, Dr. Jart+, and The Ordinary. The firm operates in 150 countries, with 26% of fiscal 2022 revenue stemming from the Americas, 43% from Europe, the Middle East, and Africa, and 31% from Asia-Pacific. The company sells its products through department stores, travel retail, multi-brand specialty beauty stores, brand-dedicated freestanding stores, e-commerce, salons/spas, and perfumeries.
Read more on EL →About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →
